Traumatology, Orthopedics, Surgery
Maxitran solution for injection 100 mg/ml in ampoules 5 ml No. 5
Other forms of release
Link to instruction in PDF format
Registration number :MA No. UA/18255/02/01
Dosage form:Solution for injection
Active substance:tranexamic acid
Composition :Each ml of the solution for injection contains 100 mg of tranexamic acid; excipients: water for injection.
Therapeutic indications :
- haemorrhage or risk of haemorrhage with increased fibrinolysis, both generalized and local, in adults and children over 1 year of age. Specific indications include: haemorrhages caused by increased general or local fibrinolysis, such as: menorrhagia and metrorrhagia;
- gastrointestinal bleeding;
- haemorrhagic disorders of the urinary tract occurred in connection with surgical intervention on the prostate gland or as a result of surgical intervention or procedures on the urinary tract;
- otolaryngological (removal of adenoids, tonsillectomy) and dental (extraction of teeth) surgical interventions;
- gynaecological surgeries or complications in obstetric practice;
- thoracic, abdominal and other major surgical interventions, for example, cardiovascular surgery;
- control of haemorrhages in connection with the administration of a fibrinolytic drug product;
Shelf life :2 роки
Other in the therapeutic group